This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
News & Press: Awards & Recognition

Tony Lubiniecki Announced as CASSS Hancock Award Winner for 2020

Friday, February 7, 2020   (1 Comments)
Posted by: Renee Olson
Share |



Wassim Nashaben, left, and Bill Hancock, right, present 
Hancock Award to 2020 recipient Tony Lubiniecki, middle.

CASSS has honored Tony Lubiniecki, PhD with its prestigious Hancock Award for Outstanding Achievements in CMC Regulatory Science.


This annual award recognizes outstanding and sustained contributions in the field of regulatory science. Lubiniecki was announced as the 2020 honoree during CASSS’s 24th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products (commonly referred to as WCBP), held in Washington, D.C., January 28-30.


“I am honored,” Lubiniecki said in accepting the award, “And humbled; because while it is I who is being honored today, the reality is that it takes thousands of hours by hundreds of people to produce these biological products that improve the lives of patients.”


In his comments to introduce this year’s honoree, CASSS President Wassim Nashabeh shared highlights of Lubiniecki’s long career. Among his achievements:


Started his career as an Assistant Research Professor of Microbiology at the Graduate School of Public Health (University of Pittsburg) working on the development of Dengue Vaccines in the 1970’s.


 Worked on Cell Culture Process Development at Genentech working on the first CHO-derived biologic (tissue plasminogen activator) in the 80’s.


He had an extended career at GSK as Vice President of Biopharmaceutical Development and at J&J/Centocor as Head of Technology Transfer and a Senior Fellow. 


He has had over 100 publications in peer-reviewed journals.


His had extensive external engagement in shaping the regulatory environment and played a key role to ensure that science is embedded in the developing regulatory processes for the nascent biotechnology industry. 


He worked through both industry associations (PhRMA & BIO) for almost 30 years, where he became the Chair of the Biotechnology Committee and was part of the development of 7 ICH guidances focused on Biotech, mainly all the Q5 series (A, B, C, D and E) as well as Q6B and Q7.  Tony has also served as a Rapporteur for Q5D as well as Q5E on comparability, arguably one of the most foundational ICH guidance’s for Biotech products that sets the basis for global biotech manufacturing, product transfers and eventually biosimilarity.


He has played a key role in the International Alliance for Biological Standards, serving on its board for over 20 years.


Editor of the internationally regarded journal Biologicals.


Served on the CASSS Board of Directors from 2016 – 2019.


Above all, Nashabeh said, “Tony embodies the early pioneering spirit that made this field what it is…follow the science, question the status quo and never falter in pursuing the unknown.”   Nashabeh continued, “I think most of us, one way or another, owe our presence here to this pioneering spirit and to leaders like Tony who founded this industry, shaped it to what it has become and serving millions of patients worldwide.


When not spending time with family and learning to play the cello, Dr. Lubiniecki is writing a history of biotechnology CMC.  The book is based on interviews and conversations with senior CMC biotechnologists who participated in the development of the field during the past 35 years. 


Joseph Kutza, AstraZeneca says...
Posted Monday, February 10, 2020
Congratulations, Tony on a well-deserved award!

more Calendar

9/14/2020 » 9/17/2020
Mass Spec 2020

9/28/2020 » 10/1/2020
CE Pharm 2020

Membership Software Powered by YourMembership  ::  Legal